ZA982562B - Chemically and thermally stable norastemizole formulations - Google Patents

Chemically and thermally stable norastemizole formulations

Info

Publication number
ZA982562B
ZA982562B ZA982562A ZA982562A ZA982562B ZA 982562 B ZA982562 B ZA 982562B ZA 982562 A ZA982562 A ZA 982562A ZA 982562 A ZA982562 A ZA 982562A ZA 982562 B ZA982562 B ZA 982562B
Authority
ZA
South Africa
Prior art keywords
chemically
thermally stable
norastemizole
formulations
norastemizole formulations
Prior art date
Application number
ZA982562A
Other languages
English (en)
Inventor
Martin P Redmon
Hal T Butler
Stephen A Wald
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of ZA982562B publication Critical patent/ZA982562B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA982562A 1997-03-26 1998-03-26 Chemically and thermally stable norastemizole formulations ZA982562B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US85178697A 1997-05-06 1997-05-06

Publications (1)

Publication Number Publication Date
ZA982562B true ZA982562B (en) 1998-10-01

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982562A ZA982562B (en) 1997-03-26 1998-03-26 Chemically and thermally stable norastemizole formulations

Country Status (13)

Country Link
EP (1) EP1035869A1 (de)
JP (1) JP2002512614A (de)
KR (1) KR20010005746A (de)
CN (1) CN1257431A (de)
AR (1) AR012187A1 (de)
BR (1) BR9808428A (de)
CA (1) CA2284705A1 (de)
HU (1) HUP0001823A3 (de)
NO (1) NO994655L (de)
NZ (3) NZ527200A (de)
RU (1) RU2214245C2 (de)
WO (1) WO1998042379A2 (de)
ZA (1) ZA982562B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EP2201982A1 (de) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamin-H4-Rezeptorantagonisten zur Behandlung von Vestibularisstörungen
EP2496217B1 (de) * 2009-08-24 2019-03-27 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Direktverpressung von otilonium

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232937B1 (de) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. N-Heterozyklische-4-piperidinamine enthaltende anti-histaminische Zusammensetzungen
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP1262183A1 (de) * 1992-09-03 2002-12-04 Sepracor, Inc. Verwendung von Norastemizol zur Behandlung der allergischen Rhinitis
KR19990067622A (ko) * 1995-11-17 1999-08-25 게리 디. 스트리트, 스티븐 엘. 네스비트 알레르기성 질환의 치료에 유용한 치환된 4-(1h-벤즈이미다졸-2-일-아미노)피페리딘
PL191073B1 (pl) * 1996-08-16 2006-03-31 Schering Corp Zastosowanie kombinacji antagonistów receptorów histaminowych H1 i H3

Also Published As

Publication number Publication date
EP1035869A1 (de) 2000-09-20
AU6868098A (en) 1998-10-20
NO994655L (no) 1999-11-15
AR012187A1 (es) 2000-09-27
JP2002512614A (ja) 2002-04-23
HUP0001823A3 (en) 2002-04-29
CN1257431A (zh) 2000-06-21
RU2214245C2 (ru) 2003-10-20
AU735257B2 (en) 2001-07-05
NO994655D0 (no) 1999-09-24
NZ517472A (en) 2003-08-29
HUP0001823A2 (hu) 2001-04-28
KR20010005746A (ko) 2001-01-15
NZ527201A (en) 2004-12-24
CA2284705A1 (en) 1998-10-01
BR9808428A (pt) 2000-05-23
WO1998042379A3 (en) 2001-03-01
WO1998042379A2 (en) 1998-10-01
NZ527200A (en) 2004-12-24

Similar Documents

Publication Publication Date Title
HK1030747A1 (en) Stable insulin formulations
PL340396A1 (en) Thermally stable polyetheramines
HUP9900812A3 (en) Thermally stabilized contrast agent
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
IL130476A0 (en) Stable glassy state powder formulations
PL339919A1 (en) Stable cosmetic compositions
GB9717598D0 (en) Novel composition and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
ZA985669B (en) New formulation
EP0934749A4 (de) Verstärkungsgewebe und dieses gewebe enthaltende ausrüstungsgegenstände
HUP9900651A3 (en) Thermally stable antistatic agent and antistatic composition comprising this agent
SI0884053T1 (en) Stable insulin formulations
GB9725946D0 (en) Lipid compositions and their use
GB2367749B (en) Depilatory compositions and their use
HUP0001823A3 (en) Chemically and thermally stable norastemizole formulations
ZA9810773B (en) Revitalisation formulation
GB9718636D0 (en) Novel composition and use
GB9706957D0 (en) Formulation
EP0998578A4 (de) Sel-10 und dessen verwendungen
PL341293A1 (en) Beta-lypothropin and application thereof
ZA984896B (en) Carbohydrates and use thereof
GB9722392D0 (en) Composition and use
GB9722390D0 (en) Composition and use
GB9712961D0 (en) Composition and use
GB9703099D0 (en) Formulations